Endoscopic Skin-Sparing vs. Conventional Mastectomy for Wound Complications in BC

ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-75
SponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University

About this trial

This randomized, open-label study compares endoscopic skin-sparing mastectomy (E-SSM) with conventional mastectomy (CM) in female patients with unilateral invasive breast cancer (T1-4aN0-3M0). The primary objective is to evaluate differences in postoperative wound complications and patient satisfaction, with secondary outcomes including breast appearance and oncological safety.

Eligible patients have a breast volume ≤ cup C and no/mild ptosis (grade I-II). A total of 258 participants (129 per group) will be enrolled across multiple centers and randomized by site.

This study aims to provide evidence for selecting optimal endoscopic surgical strategies, address the evidence gap for E-SSM without immediate reconstruction, and advance the precision of breast cancer surgery.

Eligibility criteria

Qualifiers

Female patients aged 18 to 75 years

Pathologically confirmed invasive breast cancer

Clinical stage cT1-4a N0-3 M0

Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1

Disqualifiers

Tumor invasion of the skin

Diffuse malignant microcalcifications

Breast cancer during pregnancy or lactation

History of another primary malignancy

Trial design

Treatments tested in this trial

  • Endoscopic skin-sparing mastectomy
  • Conventional mastectomy

Treatment groups

258 Participants
are divided into 2 treatment groups